All results
6 results for enroll hd huntington s disease
-
CAPTIVA
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the…
- Ages
- 30 Years - N/A
- Sexes
- All
-
CAPTIVA
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the…
- Ages
- 30 Years - N/A
- Sexes
- All
-
Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Evaluate TARE in Combination w/ Durvalumab+ Bevacizumab in People w/ Unresectable HCC (EMERALD-Y90)
The purpose of this study is to measure the efficacy and safety of durvalumab intravenous (IV) solution plus bevacizumab IV solution after transarterial…
- Ages
- 18 Years - 130 Years
- Sexes
- All
-
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mix
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia…
- Ages
- 1 Year - 25 Years
- Sexes
- All
-
Kinect-HD2
This is a Phase 3, open-label study to evaluate the long-term safety and tolerability of valbenazine, and to provide participants continued access to…
- Ages
- 18 Years - 75 Years
- Sexes
- All